3. maj · proinvestor.com
Anavex Positive OLE-Alzheimer 192 ugers data April 2025
DB, randomized, placebo-controlled] trial, those who chose to remain in the ATTENTION-AD trial knew that everyone would receive blarcamesine, as there's no longer a placebo group.
Læs artikel